RhoVac ApS | LinkedIn
  • enEnglish
  • svSvenska
  • Home
  • About Us
    ▼
    • About Chosa Oncology
    • Board of Directors
    • Team
    • Vision and strategy
  • Product
    ▼
    • iCIP™
    • LiPlaCis®
    • DRP®
    • Scientific Articles
    • Patents
  • Investors
    ▲
    • Financial Reports
    • Presentations
    • Analysis
    • Share Information
    • Event calendar
    • Corporate governance
  • News
  • Contact
  • Subscribe
RhoVac AB - Logotype
  • Home
  • About Us
    • About Chosa Oncology
    • Board of Directors
    • Team
    • Vision and strategy
  • Product
    • iCIP™
    • LiPlaCis®
    • DRP®
    • Scientific Articles
    • Patents
  • Investors
    • Financial Reports
    • Presentations
    • Analysis
    • Share Information
    • Event calendar
    • Corporate governance
  • News
  • Contact
  • Subscribe
  • CHOSA 0.00 (0)

Investors

  • Financial Reports
  • Presentations
  • Analysis
  • Share Information
  • Event calendar
  • Corporate governance

Analysis

Edison Group analysis (June 2023)


Contact

Visiting address: Medicon Village, Scheeletorget 1, Lund, Sweden | Postal address: Medicon Village AB, SE-223 81 Lund, Sweden | Org.no: 559037-2271

+46 73-751 72 78 info@chosa.bio


RhoVac has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 879817.


Cookie Policy © 2015-2023 Chosa Oncology AB All rights reserved